ReviewDrugs in context2022
Tinea versicolor: an updated review.
Review in Drugs in context, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07331792 (Comparative Efficacy of Topical 1% Clotrimazole vs Oral Itraconazole in the Treatment of Pityriasis Versicolor), which is not on this map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Comparative Efficacy of Topical 1% Clotrimazole vs Oral Itraconazole in the Treatment of Pityriasis Versicolor
Who cites it
20 citing papers in PubMed, 67 citations in OpenAlex.
- Assessment and detection of nucleotide excision repair capability in human cells: a critical review of current functional methods.Molecular biology reports · 2026Review
- Erythematous pityriasis versicolor: a case report and review of the literature.Skin health and disease · 2026Article
- Chromatic Variants of Pityriasis Versicolor and Molecular Species Identification Using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP).Journal of fungi (Basel, Switzerland) · 2026Article
- Atrophying Pityriasis Versicolor: A Rare Presentation of a Common Dermatological Disorder and Literature Review.Case reports in dermatological medicine · 2026Article
- Development of Novel Approaches for the Treatment of Cutaneous Candidiasis.Current pharmaceutical design · 2026Review
- Age-Related Clinical Patterns and Presentations of Tinea Versicolor: A Cross-Sectional Study.Cureus · 2025Article
- Atypical forms of pityriasis versicolor: Case series and literature review.JAAD case reports · 2025Article
- Challenges in diagnosing confluent and reticulated papillomatosis: a case of atypical lesions distribution.Oxford medical case reports · 2025Article
- When Pityriasis Versicolor wears a vitiligo mask: a puzzle in an immunocompromised patient.Oxford medical case reports · 2025Article
- Successful Treatment of Tinea Versicolor With Salicylic Acid 30% Peel.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2025Article
- Erythematous variant of inverse pityriasis versicolor in skin of colour.Skin health and disease · 2025Article
- Photo Quiz: Skin scraping of persistent lesion reveals the main course.Journal of clinical microbiology · 2024Article
- Article
- Biomarkers in Cutaneous Keratinocyte Carcinomas.Dermatology and therapy · 2024Review
- Impact of double-strand breaks induced by uv radiation on neuroinflammation and neurodegenerative disorders.Molecular biology reports · 2024Review
- Fungal coexistence in the skin mycobiome: a study involving Malassezia, Candida, and Rhodotorula.AMB Express · 2024Article
- Case Report: Scalp pityriasis versicolor may be a neglected problem.Frontiers in pediatrics · 2024Article
- Pityriasis Versicolor-A Narrative Review on the Diagnosis and Management.Life (Basel, Switzerland) · 2023Review
- Article
- Childhood guttate psoriasis: an updated review.Drugs in context · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tinea versicolor is a common superficial fungal infection of the skin with various clinical manifestations. This review aims to familiarize physicians with the clinical features, diagnosis and management of tinea versicolor. Methods: A search was conducted in July 2022 in PubMed Clinical Queries using the key terms "tinea versicolor" OR "pityriasis versicolor". The search strategy included all clinical trials, observational studies and reviews published within the past 10 years. Results: Tinea versicolor is caused by Conclusion: Selection of antifungal agents depends on several factors, including efficacy, safety, local availability, ease of administration, likelihood of compliance and potential drug interactions of the antifungal agent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.